Skip to main content
Home
  • About hATTR
    Amyloidosis
    • Cause and Symptoms
    • A Family Condition
  • Are you at risk
    for hATTR?
  • Taking the
    Next Step
    • Speaking With Your Healthcare Professional
    • Starting a Family Discussion
  • STAR: The Symptom
    Tracker app
  • Resources
A family living with hATTR amyloidosis
Connect with a world of information

THE BRIDGE is a program designed to help raise awareness of hereditary ATTR (hATTR) amyloidosis and provide education on the condition for patients and their families.

About hATTR amyloidosis

Learn how the condition occurs,
what symptoms may be experienced,
and how the condition can affect your family

Are you at risk for hATTR?

Use this simple assessment tool to help guide your discussion with your doctor.

Taking the next step

Read about strategies for talking
to your family and your
healthcare professional about
hATTR amyloidosis

Alnylam Pharmaceuticals
  • Sitemap
  • Contact
  • Legal
  • Privacy Policy

 

©2021 Developed and produced by Alnylam Pharmaceuticals, Inc. All Rights Reserved.

THE BRIDGE® is a registered trademark of Alnylam Pharmaceuticals, Inc. This site is intended for residents 18 years or older of Canada. All trademarks are the property of their respective owners.

TTR-CAN-00033 | May 2024.

Home

You are now leaving hattrbridge.ca 

We encourage you to read and evaluate terms of use, privacy, security and other similar policies of the destination site as they may differ from the site’s standards you are leaving.

Third Party Sites

Alnylam assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site's endorsement of Alnylam or this website.

Thank you for visiting this website.

Cancel
Continue

 

Sign up to receive updates about hereditary ATTR amyloidosis from Alnylam

*Required fields.

Thank you

Your submission has been received.

Return to site

You are now leaving The Bridge for hATTR amyloidosis

Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

OK
Cancel